Orexo internalizes contract field force in the US to further strengthen the commercial organization
Uppsala, Sweden – October 1, 2018 - Orexo AB (publ) today announces that the field representatives in the contracted field force have been offered direct employment with Orexo US Inc. starting October 1, 2018. The decision follows on the positive outcome in the patent litigation against Actavis, the continued revenue growth and significant improvement in the profit contribution from Orexo US Inc. during first half of 2018. To secure flexibility in the field force and the ability to rapidly adapt to changing market dynamics it has since the launch of Zubsolv® in the US in 2013 been an